CFM
GSK icon

Capricorn Fund Managers’s GSK GSK Stock Holding History

Capricorn Fund Managers’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$22.4M Buy
+426,416
New +$22.6M 1.76% 13

Other funds holding GSK

LMFP
Larry Mathis Financial Planning Phoenix, Arizona $124B AUM
DLA
Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return
TNB
Thomasville National Bank Thomasville, Georgia $1.82B AUM
AA
ABC Arbitrage Paris, France $926M AUM 45.9% 1-Year Est. Return
FVWA
Foster Victor Wealth Advisors Greenville, South Carolina $1.9B AUM 24.46% 1-Year Est. Return
SIS
Sound Income Strategies Ft Lauderdale, Florida $2.23B AUM 11.22% 1-Year Est. Return
KFP
Keystone Financial Planning Cleveland, Ohio $388M AUM 16.66% 1-Year Est. Return
QCM
QRG Capital Management Chicago, Illinois $12.1B AUM 44.98% 1-Year Est. Return
TH
Transmarket Holdings Chicago, Illinois $136M AUM
GC
Grimes & Company Westborough, Massachusetts $4.62B AUM 29.71% 1-Year Est. Return

Capricorn Fund Managers's GSK Position: Q2 2026 in Review

Capricorn Fund Managers opened a new position in GSK (GSK) in Q2 2026: 426,416 shares worth $22.4M. The stake represents 1.76% of the portfolio and ranks #13 among its holdings.

277 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • Capricorn Fund Managers held 426,416 shares of GSK worth $22.4M as of Q2 2026.
  • GSK was a new Capricorn Fund Managers position in Q2 2026.
  • GSK made up 1.76% of Capricorn Fund Managers's portfolio in Q2 2026, its #13 holding.
  • 277 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Capricorn Fund Managers's 13F filing for Q2 2026, filed 24 Jul 2026.